Possible role of BDNF-induced microglial intracellular ca2+ elevation in the pathophysiology of neuropsychiatric disorders

Mini-Reviews in Medicinal Chemistry

Volumn 11, Issue 7, 2011, Pages 575-581

  Mizoguchi, Y ^a,b   Monji, A ^b   Kato, T A ^b   Horikawa, H ^b   Seki, Y ^b   Kasai, M ^b   Kanba, S ^b   Yamada, S ^a  

^a SAGA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

BDNF; Calcium; Depression; Inflammation; Microglia; Schizophrenia; TRP channels

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CALCIUM; NITRIC OXIDE; PAROXETINE; SERTRALINE; TRANSIENT RECEPTOR POTENTIAL CHANNEL;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL ACTIVATION; CELL FUNCTION; MENTAL DISEASE; MICROGLIA; NEUROLOGIC DISEASE; NEUROPSYCHIATRIC DISORDER; NONHUMAN; PATHOPHYSIOLOGY; RECEPTOR BINDING; STORE OPERATED CALCIUM ENTRY CHANNEL;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CALCIUM; CATIONS, DIVALENT; HUMANS; INFLAMMATION; MICROGLIA; NEUROTIC DISORDERS;

EID: 79959981701     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/138955711795906932     Document Type: Article

References (78)

1. Block, M. L.; Zecca, L.; Hong, J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci., 2007, 8, 57-69.
2. Hanisch, U. K.; Kettenmann, H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci., 2007, 10, 1387-1394.
3. Rivest, S. Regulation of innate immune responses in the brain. Nat. Rev. Immunol., 2009, 9, 429-439.
4. Graeber, M.B. Changing face of microglia. Science, 2010, 330, 783-788.
5. Nimmerjahn, A.; Kirchhoff, F.; Helmchen, F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science, 2005, 308, 1314-1318.
6. Wake, H.; Moorhouse, A. J.; Jinno, S.; Kohsaka, S.; Nabekura, J. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J. Neurosci., 2009, 29, 3974-3980.
7. van Berckel, B. N.; Bossong, M.G.; Boellaard, R.; Kloet, R.; Schuitemaker, A.; Caspers, E.; Luurtsema, G.; Windhorst, A. D.; Cahn, W.; Lammertsma, A.A.; Kahn, R.S. Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study. Biol. Psychiatry, 2008, 64, 820-882.
8. Dantzer, R.; O'Connor, J.C.; Freund, G.G.; Johnson, R.W.; Kelley, K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci., 2008, 9, 46-56.
9. Müller, N.; Schwarz, M.J. A psychoneuroimmunological perspective to Emil Kraepelins dichotomy: schizophrenia and major depression as inflammatory CNS disorders. Eur. Arch. Psychiatry Clin. Neurosci., 2008, 258, Suppl., 2, 97-106.
10. Minichiello, L. TrkB signalling pathways in LTP and learning. Nat. Rev. Neurosci., 2009, 10, 850-860.
11. Poo, M. M. Neurotrophins as synaptic modulators. Nat. Rev. Neurosci., 2001, 2, 24-32.
12. Lu, B.; Pang, P. T.; Woo, N. H. The yin and yang of neurotrophin action. Nat. Rev. Neurosci., 2005, 6, 603-614.
13. Mizoguchi, Y.; Kanematsu, T.; Hirata, M.; Nabekura, J. A rapid increase in the total number of cell surface functional GABAA receptors induced by brain-derived neurotrophic factor in rat visual cortex. J. Biol. Chem., 2003, 278, 44097-44102.
14. Mizoguchi, Y.; Ishibashi, H.; Nabekura, J. The action of BDNF on GABA(A) currents changes from potentiating to suppressing during maturation of rat hippocampal CA1 pyramidal neurons. J. Physiol., 2003, 548, 703-709.
15. Mizoguchi, Y.; Kitamura, A.; Wake, H.; Ishibashi, H.; Watanabe, M.; Nishimaki, T.; Nabekura, J. BDNF occludes GABA receptormediated inhibition of GABA release in rat hippocampal CA1 pyramidal neurons. Eur. J. Neurosci., 2006, 24, 2135-2144.
16. + currents in rat visual cortex neurons. Eur. J. Neurosci., 2002, 16, 1417-1424.
17. Lang, S.B.; Stein, V.; Bonhoeffer, T.; Lohmann, C. Endogenous brain-derived neurotrophic factor triggers fast calcium transients at synapses in developing dendrites. J. Neurosci., 2007, 27, 1097- 1105.
18. Rose, C. R.; Blum, R.; Pichler, B.; Lepier, A.; Kafitz, K. W.; Konnerth, A. Truncated TrkB-T1 mediates neurotrophin-evoked calcium signalling in glia cells. Nature, 2003, 426, 74-78.
19. Angelucci, F.; Brenè, S.; Mathé, A. A. BDNF in schizophrenia, depression and corresponding animal models. Mol.Psychiatry, 2005, 10, 345-352.
20. Berton, O.; Nestler, E. J New approaches to antidepressant drug discovery: beyond monoamines. Nat. Rev. Neurosci., 2006, 7, 137-151.
21. Duman, R.S.; Monteggia, L. M. A neurotrophic model for stressrelated mood disorders. Biol. Psychiatry, 2006, 59, 1116-1127.
22. Li, Y.; Luikart, B. W.; Birnbaum, S.; Chen, J.; Kwon, C. H.; Kernie, S. G.; Bassel-Duby, R.; Parada, L. F. TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment. Neuron, 2008, 59, 399-412.
23. Sen, S.; Duman, R.; Sanacora, G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol. Psychiatry, 2008, 64, 527-532.
24. Hashimoto, K. Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions. Psychiatry Clin. Neurosci., 2010, 64, 341-357.
25. Kunugi, H.; Hori, H.; Adachi, N.; Numakawa, T. Interface between hypothalamic-pituitary-adrenal axis and brain-derived neurotrophic factor in depression. Psychiatry Clin. Neurosci., 2010, 64, 447-459.
26. Nitta, A.; Ohmiya, M.; Sometani, A.; Itoh, M.; Nomoto, H.; Furukawa, Y.; Furukawa, S. Brain-derived neurotrophic factor prevents neuronal cell death induced by corticosterone. J. Neurosci. Res., 1999, 57, 227-235.
27. Wolkowitz, O. M.; Epel, E. S.; Reus, V. I.; Mellon, S. H. Depression gets old fast: do stress and depression accelerate cell aging? Depress. Anxiety, 2010, 27, 327-338.
28. Elkabes, S.; DiCicco-Bloom, E. M.; Black, I. B. Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function. J. Neurosci., 1996, 16, 2508-2521.
29. Nakajima, K.; Honda, S.; Tohyama, Y.; Imai, Y.; Kohsaka, S.; Kurihara, T. Neurotrophin secretion from cultured microglia. J. Neurosci. Res., 2001, 65, 322-331.
30. Zhang, J.; Geula, C.; Lu, C.; Koziel, H.; Hatcher, L. M.; Roisen, F. J. Neurotrophins regulate proliferation and survival of two microglial cell lines in vitro. Exp. Neurol., 2003, 183, 469-481.
31. Batchelor, P. E.; Liberatore, G. T.; Wong, J. Y.; Porritt, M. J.; Frerichs, F.; Donnan, G. A.; Howells, D. W. Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J. Neurosci., 1999, 19, 1708-1716.
32. Coull, J.A.; Beggs, S.; Boudreau, D.; Boivin, D.; Tsuda, M.; Inoue, K.; Gravel, S.; Salter, M. W.; De Koninck, Y. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature, 2005, 438, 1017-1021.
33. Berridge, M. J.; Bootman, M. D.; Roderick, H. L. Calcium signalling: dynamics, homeostasis and remodelling. Nat. Rev. Mol. Cell. Biol., 2003, 4, 517-529.
34. Eder, C. Regulation of microglial behavior by ion channel activity. J. Neurosci. Res., 2005, 81, 314-321.
35. Färber, K.; Kettenmann, H. Functional role of calcium signals for microglial function. Glia, 2006, 54, 656-665.
36. Trang, T.; Beggs, S.; Wan, X.; Salter, M. W. P2X4-receptormediated synthesis and release of brain-derived neurotrophic factor in microglia is dependent on calcium and p38-mitogen-activated protein kinase activation. J. Neurosci., 2009, 29, 3518-3528.
37. Lidow, M. S. Calcium signaling dysfunction in schizophrenia: a unifying approach. Brain Res. Brain Res.Rev., 2002, 43, 70-84.
38. Bojarski, L.: Debowska, K.: Wojda, U. In vitro findings of alterations in intracellular calcium homeostasis in schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2010, 34, 1367-1374.
39. Kato, T. Role of mitochondrial DNA in calcium signaling abnormality in bipolar disorder. Cell Calcium, 2008, 44, 92-102.
40. 2+ signalling in transformed lymphoblastoid cells from patients with bipolar disorder. Int. J. Neuropsychopharmacol., 2003, 6, 379-389.
41. Wasserman, M. J.; Corson, T.W.; Sibony, D.; Cooke, R. G.; Parikh, S. V.; Pennefather, P. S.; Li, P. P.; Warsh, J. J. Chronic lithium treatment attenuates intracellular calcium mobilization. Neuropsychopharmacology, 2004, 29, 759-769.
42. 2+ responses in B lymphoblasts by mood stabilizers. Int. J. Neuropsychopharmacol., 2010, 13, 693-702.
43. Hashioka, S.; Klegeris, A.; Monji, A.; Kato, T.; Sawada, M.; McGeer, P. L.; Kanba, S. Antidepressants inhibit interferongamma- induced microglial production of IL-6 and nitric oxide. Exp. Neurol., 2007, 206, 33-42.
44. Horikawa, H.; Kato, T. A.; Mizoguchi, Y.; Monji, A.; Seki, Y.; Ohkuri, T.; Gotoh, L.; Yonaha, M.; Ueda, T.; Hashioka, S.; Kanba, S. Inhibitory effects of SSRIs on IFN-γ induced microglial activation through the regulation of intracellular calcium. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2010, 34, 1306-1316.
45. Kato, T.; Monji, A.; Hashioka, S.; Kanba. S. Risperidone significantly inhibits interferon-gamma-induced microglial activation in vitro. Schizophr. Res., 2007, 92, 108-115.
46. 2+ regulation in vitro. J. Neurochem., 2008, 106, 815-825.
47. 2+ in rodent microglia. J. Immunol., 2009, 183, 7778-7786.
48. 2+ mobilization and functional responses in microglia: effects of low levels of ATP. J. Neurosci. Res., 2005, 81, 349-356.
49. Choi, D.Y.; Toledo-Aral, J. J.; Segal, R.; Halegoua, S. Sustained signaling by phospholipase C-γ mediates nerve growth factortriggered gene expression. Mol. Cell. Biol., 2001, 21, 2695-2705.
50. Patapoutian, A.; Reichardt, L. F. Trk receptors: mediators of neurotrophin action. Curr. Opin. Neurobiol., 2001, 11, 272-280.
51. Rose, C. R.; Blum, R.; Kafitz, K. W.; Kovalchuk, Y.; Konnerth, A. From modulator to mediator: rapid effects of BDNF on ion channels. Bioessays, 2004, 26, 1185-1194.
52. Ohira, K.; Kumanogoh, H.; Sahara, Y.; Homma, K. J.; Hirai, H.; Nakamura, S.; Hayashi, M. A truncated tropomyosin-related kinase B receptor, T1, regulates glial cell morphology via Rho GDP dissociation inhibitor 1. J. Neurosci., 2005, 25, 1343-1353.
53. Climent, E.; Sancho-Tello, M.; Miñana, R.; Barettino, D.; Guerri, C. Astrocytes in culture express the full-length Trk-B receptor and respond to brain derived neurotrophic factor by changing intracellular calcium levels: effect of ethanol exposure in rats. Neurosci. Lett., 2000, 288, 53-56.
54. Carim-Todd, L.; Bath, K. G.; Fulgenzi, G.; Yanpallewar, S.; Jing, D.; Barrick, C. A.; Becker, J.; Buckley, H.; Dorsey, S. G.; Lee, F. S.; Tessarollo, L. Endogenous truncated TrkB.T1 receptor regulates neuronal complexity and TrkB kinase receptor function in vivo. J. Neurosci., 2009, 29, 678-685.
55. Ernst, C.; Deleva, V.; Deng, X.; Sequeira, A.; Pomarenski, A.; Klempan, T.; Ernst, N.; Quirion, R.; Gratton, A.; Szyf, M.; Turecki, G. Alternative splicing, methylation state, and expression profile of tropomyosin-related kinase B in the frontal cortex of suicide completers. Arch. Gen. Psychiatry, 2009, 66, 22-32.
56. Möller, T. Calcium signaling in microglial cells. Glia, 2002, 40, 184-194.
57. Amaral, M. D.; Pozzo-Miller, L. TRPC3 channels are necessary for brain-derived neurotrophic factor to activate a nonselective cationic current and to induce dendritic spine formation. J. Neurosci., 2007, 27, 5179-5189.
58. Li, Y.; Jia, Y. C.; Cui, K.; Li, N.; Zheng, Z. Y.; Wang, Y. Z.; Yuan, X. B. Essential role of TRPC channels in the guidance of nerve growth cones by brain-derived neurotrophic factor. Nature, 2005, 434, 894-898.
59. Shirakawa, H.; Sakimoto, S.; Nakao, K.; Sugishita, A.; Konno, M.; Iida, S.; Kusano, A.; Hashimoto, E.; Nakagawa, T.; Kaneko, S. Transient receptor potential canonical 3 (TRPC3) mediates thrombin-induced astrocyte activation and upregulates its own expression in cortical astrocytes. J. Neurosci., 2010, 30, 13116-13129.
60. Nilius, B.; Owsianik, G.; Voets, T.; Peters, J. A. Transient receptor potential cation channels in disease. Physiol. Rev., 2007, 87, 165-217.
61. Nakajima, K.; Kikuchi, Y.; Ikoma, E.; Honda, S.; Ishikawa, M.; Liu, Y.; Kohsaka, S. Neurotrophins regulate the function of cultured microglia. Glia, 1998, 24, 272-289.
62. Gough, D. J.; Levy, D. E.; Johnstone, R. W.; Clarke, C. J. IFNgamma signaling-does it mean JAK-STAT? Cytokine Growth Factor Rev., 2008, 19, 383-394.
63. 2+ and CaMKII for Stat1 Ser-727 phosphorylation in response to IFN-γProc. Natl. Acad. Sci. U.S. A., 2002, 99, 5971-5976.
64. Hoffmann, A.; Kann, O.; Ohlemeyer, C.; Hanisch, U. K.; Kettenmann, H. Elevation of basal intracellular calcium as a central element in the activation of brain macrophages (microglia): suppression of receptor-evoked calcium signaling and control of release function. J. Neurosci., 2003, 23, 4410-4419.
65. Hall, A. A.; Herrera, Y.; Ajmo, C. T. Jr.; Cuevas, J.; Pennypacker, K. R. Sigma receptors suppress multiple aspects of microglial activation. Glia, 2009, 57, 744-754.
66. Yagasaki, Y.; Numakawa, T.; Kumamaru, E.; Hayashi, T.; Su, T. P.; Kunugi, H. Chronic antidepressants potentiate via sigma-1 receptors the brain-derived neurotrophic factor-induced signaling for glutamate release. J. Biol. Chem., 2006, 281, 12941-12949.
67. Nishimura, T.; Ishima, T.; Iyo, M.; Hashimoto, K. Potentiation of nerve growth factor-induced neurite outgrowth by fluvoxamine: role of sigma-1 receptors, IP3 receptors and cellular signaling pathways. PLoS One, 2008, 3, e2558.
68. Gekker, G.; Hu, S.; Sheng, W. S.; Rock, R. B.; Lokensgard, J. R.; Peterson, P. K. Cocaine-induced HIV-1 expression in microglia involves sigma-1 receptors and transforming growth factor-beta1. Int. Immunopharmacol., 2006, 6, 1029-1033.
69. Narita, N.; Hashimoto, K.; Tomitaka, S.; Minabe, Y. Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain. Eur. J. Pharmacol., 1996, 307, 117-119.
70. Yong, V. W. Metalloproteinases: mediators of pathology and regeneration in the CNS. Nat. Rev. Neurosci., 2005, 6, 931-944.
71. Greenberg, M. E.; Xu, B.; Lu, B.; Hempstead, B. L. New insights in the biology of BDNF synthesis and release: implications in CNS function. J. Neurosci., 2009, 29, 12764-12767.
72. Yune, T.Y.; Lee, J. Y.; Jung, G. Y.; Kim, S. J.; Jiang, M. H.; Kim, Y. C.; Oh, Y.J.; Markelonis, G. J.; Oh, T. H. Minocycline alleviates death of oligodendrocytes by inhibiting pro-nerve growth factor production in microglia after spinal cord injury. J. Neurosci., 2007, 27, 7751-7761.
73. Egan, M. F.; Kojima, M.; Callicott, J. H.; Goldberg, T. E.; Kolachana, B. S.; Bertolino, A.; Zaitsev, E.; Gold, B.; Goldman, D.; Dean, M.; Lu, B.; Weinberger, D. R. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell, 2003, 112, 257-269.
74. Frodl, T.; Schüle, C.; Schmitt, G.; Born, C.; Baghai, T.; Zill, P.; Bottlender, R.; Rupprecht, R.; Bondy, B.; Reiser, M.; Möller, H. J.; Meisenzahl, E. M. Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. Arch. Gen. Psychiatry, 2007, 64, 410-416.
75. Martinowich, K.; Manji, H.; Lu, B. New insights into BDNF function in depression and anxiety. Nat. Neurosci., 2007, 10, 1089- 1093.
76. Jang, S. W.; Liu, X.; Yepes, M.; Shepherd. K.R.; Miller, G. W.; Liu, Y.; Wilson, W. D.; Xiao, G.; Blanchi, B.; Sun, Y. E.; Ye, K. A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone. Proc. Natl. Acad. Sci. U. S. A., 2010, 107, 2687-2692.
77. Andero, R.; Heldt, S. A.; Ye, K.; Liu, X.; Armario, A.; Ressler, K.J. Effect of 7,8 Dihydroxyflavone, a small-molecule TrkB agonist, on emotional learning. Am. J. Psychiatry, 2010, In press.
78. Raison, C.L.; Lowry, C. A.; Rook, G. A. Inflammation, sanitation, and consternation: loss of contact with coevolved, tolerogenic microorganisms and the pathophysiology and treatment of major depression. Arch. Gen. Psychiatry, 2010, 67, 1211-1224.